The DOI matches its Crossref record; 20 of the 20 references it cites were found in a registry or an index.
Impact of BAL Data on the Therapy and Outcome of Ventilator-Associated Pneumonia
Open accessAbstract
STUDY OBJECTIVE: To define the impact of BAL data on the selection of antibiotics and the outcomes of patients with ventilator-associated pneumonia (VAP). DESIGN: Prospective observation and bronchoscopy with BAL, performed within 24 h of establishing a clinical diagnosis of a new episode of hospital-acquired VAP or progression of a prior episode of nosocomial pneumonia (NP). SETTING: A 15-bed medical and surgical ICU. PATIENTS: One hundred thirty-two patients hospitalized for more than 72 h, who were mechanically ventilated and had a new or progressive lung infiltrate plus at least two of the following three clinical criteria for VAP: abnormal temperature (> 38 degrees C or < 35 degrees C), abnormal leukocyte count (> 10,000/mm3 or < 3,000/mm3), purulent bronchial secretions. INTERVENTIONS: Bronchoscopy with BAL within 24 h of establishing a clinical diagnosis of VAP or progression of an infiltrate due to prior VAP or NP. All patients received antibiotics, 107 prior to bronchoscopy and 25 immediately after bronchoscopy. RESULTS: Sixty-five of the 132 patients were BAL positive (BAL[+]), satisfying a microbiologic definition of VAP (> 10(4) cfu/mL), while 67 were BAL negative (BAL[-]). The BAL(+) patients had no differences in mortality, prior antibiotic use, and demographic features when compared with the BAL(-) patients. More of the BAL(+) patients (38/65) satisfied all three clinical criteria of VAP than did BAL(-) patients (24/67) (p < 0.05). A total of 50 BAL(+) patients received antibiotic therapy prior to bronchoscopy, and when this prior therapy was adequate (n = 16), as defined by the results of BAL, then mortality was 38%, while if prior therapy was inadequate (n = 34), mortality was 91% (p < 0.001), and if no therapy was given (n = 15), mortality was 60%. When therapy changes were made after bronchoscopy, more patients (n = 42) received adequate therapy, but mortality in this group was comparable to mortality among those who continued to receive inadequate therapy (n = 23). A total of 46 of the 65 BAL(+) patients died, with 23 of these deaths occurring during the 48 h after the bronchoscopy, before BAL results were known. When BAL data became available, 37 of the 42 surviving patients received adequate therapy, but their mortality was comparable to the patients who continued to receive inadequate therapy. CONCLUSIONS: Patients with a strong clinical suspicion of VAP have a high mortality rate, regardless of whether BAL cultures confirm the clinical diagnosis of VAP. When adequate antibiotic therapy is initiated very early (ie, before performing bronchoscopy), mortality rate is reduced if this empiric therapy is adequate, compared to when this therapy is inadequate or no therapy is given. If adequate therapy is delayed until bronchoscopy is performed or until BAL results are known, mortality is higher than if it had been given at the time of first establishing a clinical diagnosis of VAP. When patients were changed from inadequate antibiotic therapy to adequate therapy, based on the results of BAL, mortality was comparable to those who continued to receive inadequate therapy. Thus, even if bronchoscopy can accurately define the microbial etiology of VAP, this information becomes available too late to influence survival.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Gram-Negative Bacteremia: I. Etiology and Ecology
McCABE, W. R. (1962) · Archives of Internal Medicine · doi:10.1001/archinte.1962.03620240029006 · Cited by 1,362
Fagon, J.-Y., Chastre, J., Hance, A. J., Montravers, P., Novara, A., & Gibert, C. (1993) · The American Journal of Medicine · doi:10.1016/0002-9343(93)90060-3 · Cited by 1,180
Pugin, J., Auckenthaler, R., Mili, N., Janssens, J.-P., Lew, P. D., & Suter, P. M. (1991) · American Review of Respiratory Disease · doi:10.1164/ajrccm/143.5_pt_1.1121 · Cited by 1,132
Incidence, Risk, and Prognosis Factors of Nosocomial Pneumonia in Mechanically Ventilated Patients
Torres, A., Aznar, R., Gatell, J. M., Jiménez, P., González, J., Ferrer, A., Celis, R., & Rodriguez-Roisin, R. (1990) · American Review of Respiratory Disease · doi:10.1164/ajrccm/142.3.523 · Cited by 916
Fagon, J.-Y., Chastre, J., Domart, Y., Trouillet, J.-L., Pierre, J., Darne, C., & Gibert, C. (1989) · American Review of Respiratory Disease · doi:10.1164/ajrccm/139.4.877 · Cited by 823
Celis, R., Torres, A., Gatell, J. M., Almela, M., Rodríguez-Roisin, R., & Agustí-Vidal, A. (1988) · Chest · doi:10.1378/chest.93.2.318 · Cited by 683
Rello, J., Ausino, V., Ricart, M., Castella, J., & Prats, G. (1993) · Chest · doi:10.1378/chest.104.4.1230 · Cited by 482
Fagon, J.-Y., Chastre, J., Hance, A. J., Guiguet, M., Trouillet, J.-L., Domart, Y., Pierre, J., & Gibert, C. (1988) · American Review of Respiratory Disease · doi:10.1164/ajrccm/138.1.110 · Cited by 426
Chastre, J. E., Viau, F., Brun, P., Pierre, J., Dauge, M., Bouchama, A., Akesbi, A., & Gibert, C. (1984) · PubMed · doi:10.1164/arrd.1984.130.5.924 · Cited by 355
Chastre, J., Fagon, J.-Y., Soler, P., Bornet, M., Domart, Y., Trouillet, J.-L., Gibert, C., & Hange, A. J. (1988) · The American Journal of Medicine · doi:10.1016/s0002-9343(88)80085-8 · Cited by 329
Bronchoalveolar Lavage for Diagnosing Acute Bacterial Pneumonia
Thorpe, J. E., Baughman, R. P., Frame, P. T., Wesseler, T. A., & Staneck, J. L. (1987) · Journal of Infectious Diseases · doi:10.1093/infdis/155.5.855 · Cited by 317
Torres, A., De La Bellacasa, J. P., Xaubet, A., Gonzalez, J., Rodríguez-Roisin, R., De Anta, M. T. J., & Vidal, A. A. (1989) · American Review of Respiratory Disease · doi:10.1164/ajrccm/140.2.306 · Cited by 258
Follow-up Protected Specimen Brushes to Assess Treatment in Nosocomial Pneumonia
Montravers, P., Fagon, J.-Y., Chastre, J., Lecso, M., Dombret, M. C., Trouillet, J.-L., & Gibert, C. (1993) · American Review of Respiratory Disease · doi:10.1164/ajrccm/147.1.38 · Cited by 241
Incidence, site, and outcome of infections in patients with the adult respiratory distress syndrome.
Seidenfeld, J. J., Pohl, D. F., Bell, R. C., Harris, G., & JOHANSON, W. G. (1986) · PubMed · doi:10.1164/arrd.1986.134.1.12 · Cited by 238
Niederman, M. S., Torres, A., & Summer, W. (1994) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.150.2.8049849 · Cited by 234
Self-citationMeduri, G. U., Beals, D. H., Maijub, A. G., & Baselski, V. (1991) · American Review of Respiratory Disease · doi:10.1164/ajrccm/143.4_pt_1.855 · Cited by 182
Chastre, J., & Fagon, J. Y. (1994) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.150.2.8049850 · Cited by 181
Management of Bacterial Pneumonia in Ventilated Patients
Meduri, G. U., Wunderink, R. G., Leeper, K. V., et al. (1992) · CHEST Journal · doi:10.1378/chest.101.2.500 · Cited by 91
Pneumonia in the Critically III Hospitalized Patient
Niederman, M. S., Craven, D. E., Fein, A. M., & Schultz, D. E. (1990) · CHEST Journal · doi:10.1378/chest.97.1.170 · Cited by 81
Self-citationMortality and Ventilator-associated Pneumonia
Wunderink, R. G. (1993) · CHEST Journal · doi:10.1378/chest.104.4.993b · Cited by 28
Cited by
(2005) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200405-644st · Cited by 5,877
Ventilator-associated Pneumonia
Chastre, J., & Fagon, J.-Y. (2002) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.165.7.2105078 · Cited by 2,812
Inadequate Antimicrobial Treatment of Infections
Kollef, M. H., Sherman, G., Ward, S., & Fraser, V. J. (1999) · Chest · doi:10.1378/chest.115.2.462 · Cited by 1,805
Ibrahim, E. H., Sherman, G., Ward, S., Fraser, V. J., & Kollef, M. H. (2000) · Chest · doi:10.1378/chest.118.1.146 · Cited by 1,779
Torres, A., Niederman, M. S., Chastre, J., Ewig, S., Fernandez-Vandellos, P., Hanberger, H., Kollef, M., Li Bassi, G., Luna, C. M., Martin-Loeches, I., et al. (2017) · European Respiratory Journal · doi:10.1183/13993003.00582-2017 · Cited by 1,387
Self-citation
Metadata
- Authors
- Luna, C. M., Vujacich, P., Niederman, M. S., Vay, C., Gherardi, C., Matera, J., & Jolly, E. C.
- Venue
- Chest
- Publisher
- Elsevier BV
- Published
- 1997-03
- Volume
- 111
- Issue
- 3
- Pages
- 676-685
- ISSN
- 0012-3692 (ISSN-L)
- OpenAlex
- W2091493523
- Cited by
- 916
- References
- 20
- FWCI
- 27.41
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.